Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC) [Phase 3]
This update describes an Asian Phase 3 trial evaluating Sacituzumab Govitecan (IMMU-132) for HR+/HER2- metastatic breast cancer, with the st…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Dissemination of BREASTChoice AIM1-B [NA]
This clinical trial update indicates that recruitment is ongoing for the BREASTChoice AIM1-B study related to breast cancer, disseminated by…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
A clinical trial at Abramson Cancer Center investigates the effects of immune checkpoint inhibitors on the coronary microvasculature, with a…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
This clinical trial update describes a study evaluating responses to genetic risk modifier testing in women with BRCA1/2 mutations; the stud…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating the combination of focused ultrasound with pembrolizumab in metastatic breast cancer has been terminated with resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers [Phase 4]
This Phase 4 study investigates whether morning versus evening dosing of endocrine-based therapies improves outcomes in metastatic breast ca…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Pilot Observational Study of an Integrative Cure Stay Program
This document reports a pilot observational study at University Hospital Basel evaluating an integrative 'Cure Stay' program for patients wi…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Cardiotoxicity of Cancer Therapy (CCT)
The Cardiotoxicity of Cancer Therapy (CCT) trial, sponsored by the Abramson Cancer Center at Penn Medicine, is enrolling by invitation in br…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib [Phase 2]
Phase 2 clinical trial evaluating radiotherapy combined with Anlotinib for HER2-negative breast cancer with brain metastases; currently recr…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast [Phase 2]
This Phase 2 trial investigates repeat breast-conserving surgery followed by daily partial breast irradiation in the ipsilateral breast, wit…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer [NA]
This clinical trials update describes pregnancy outcomes and the safety of interrupting endocrine therapy for women with endocrine-responsiv…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors [Phase 1]
A Phase 1 clinical trial evaluating a virtual mindfulness-based intervention called Mindful After Cancer (MAC) to promote sexual health in b…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease [Phase 1, Phase 2]
This is an early-phase trial evaluating radiation therapy followed by intrathecal trastuzumab and pertuzumab for HER2-positive breast cancer…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1-2 study of ST101 in patients with advanced solid tumors, including glioblastoma and melanoma. The trial is currently active but not …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE) [Phase 2]
Phase 2 trial evaluating the combination of elacestrant and exemestane in pretreated HR+/HER2- metastatic breast cancer; the study is not ye…
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of IDE161, a PARG inhibitor, is recruiting in patients with several solid tumor types including breast, ovarian, and various l…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Study of Screening Brain MRIs in Stage IV Breast Cancer
A clinical trial at H. Lee Moffitt Cancer Center is evaluating the use of screening brain MRIs in patients with Stage IV breast cancer, incl…
-
EMA approval · 2026-02-06EMA Authorised: Alymsys (bevacizumab) — Mabxience Research SL
The EMA authorised Alymsys, a bevacizumab biosimilar from Mabxience Research SL. It is approved for multiple cancer indications including co…
-
EMA approval · 2026-02-06EMA Authorised: Tuznue (trastuzumab) — Prestige Biopharma Belgium
The European Medicines Agency authorised Tuznue (trastuzumab) from Prestige Biopharma Belgium for breast cancer indications.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation [NA]
A randomized two-arm proof-of-concept clinical trial evaluating a novel affect-regulation-based approach to promoting exercise in breast can…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: BreastCancerPEP: A Six-Month Online Empowerment Program to Improve Mental and Physical Health in Women With Breast Cancer [NA]
This clinical trial entry describes an online six-month empowerment program for women with breast cancer, aimed at improving mental and phys…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer [Phase 2]
This document notes a Phase 2 neoadjuvant trial investigating trastuzumab deruxtecan (SHR-A1811) in combination with pertuzumab for HER2-pos…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating a binary oncolytic adenovirus in combination with a HER2-specific autologous CAR-VST for advanced HER2-pos…
-
CLINICAL_TRIALS withdrawal · 2026-02-06Clinical Trial Update: Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging [Phase 1, Phase 2]
Clinical trial NCT04273555 evaluating early response to a targeted therapy in stage IV HER2-positive breast cancer using advanced PET/MR ima…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of stereotactic radiation and abemaciclib for HR-positive, HER2-negative metastatic breast canc…